Huadong Medicine Co., Ltd (SHE: 000963)

Market Cap	58.09B
Revenue (ttm)	41.71B
Net Income (ttm)	3.21B
Shares Out	1.75B
EPS (ttm)	1.83
PE Ratio	18.10
Forward PE	19.02
Dividend	0.70 (2.02%)
Ex-Dividend Date	Sep 20, 2024

Volume	12,709,870
Open	35.98
Previous Close	34.60
Day's Range	33.00 - 35.98
52-Week Range	25.96 - 40.66
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 11, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co. Ltd. has strategic cooperation agreement with SynerK PharmaTech (Suzhou) Co. Ltd. to develop the small nucl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 16,969
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2023, Huadong Medicine's revenue was 40.62 billion, an increase of 7.71% compared to the previous year's 37.71 billion. Earnings were 2.84 billion, an increase of 13.59%.